Electromagnetic Field Versus Diclofenac Drugs on Primary Dysmenorrhea

• Status: Completed
• Trial end date: 2016-10-29
• Target enrollment: 0
• Participant gender: Female

Summary

Electromagnetic field versus diclofenac drugs on primary dysmenorrhea: Arandomized controlled trial in the Egyptian women

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Diclofenac; Progesterone

Criteria

Inclusion Criteria:

-regular menstrual cycle 21-35 days lasting 3-7 days

Exclusion Criteria:

• Irregulars or infrequent menstrual cycles, Pacemaker, Myasthenia gravis, hyperthyroidism, active tuberculosis and psychosis